AVAV vs CRS Stock Comparison
CRS currently leads AVAV in this stock comparison, with AIQ scores of 45 vs 39. The clearest difference is quality, while AVAV has the stronger value profile.
What is the main difference between AVAV and CRS?
CRS leads the current stock comparison as Carpenter Technology Corporation, with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
AeroVironment, Inc. vs Carpenter Technology Corporation
CRS leads
CRS leads by 6 AIQ points, primarily on Quality and Risk Resilience, but the lead has narrowed from 9 points over 30 sessions. Wall Street currently favors AVAV on target upside.
Fragile: 3 of 6 evidence groups support CRS, and its lead is narrowing.
AeroVironment, Inc.
Carpenter Technology Corporation
The Algovestiq AIQ Score currently favors CRS over AVAV, 45 versus 39 as of Nov 15, 2026. CRS's advantage is driven primarily by stronger quality and risk resilience, while AVAV holds the stronger value profile. CRS also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors AVAV. 3 of 6 covered evidence groups favor CRS today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. CRS lead: Weakening — the AIQ differential moved from 9 to 6 points over 30 sessions.
Compare AeroVironment, Inc. and Carpenter Technology Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AVAV and CRS against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality47 vs 74CRS +27
- Risk Resilience35 vs 48CRS +13
- Value50 vs 41AVAV +9
- Momentum29 vs 20AVAV +9
3 of 6 evidence groups favor CRS. CRS’s edge is concentrated in quality and risk resilience; AVAV keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +2, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 5 active signals are unchanged.
Largest factor move: Quality -3, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 4 active signals are unchanged.
CRS's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — AVAV and CRS both carry a full feed there.
The central trade-off
CRS (Carpenter Technology Corporation): the stronger current systematic profile, led by quality and risk resilience.
AVAV (AeroVironment, Inc.): the counter-case, on value, momentum, valuation.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CRSCRS on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AVAVAVAV on combined revenue and EPS growth.
Value
AVAVAVAV on the peer-relative Value factor, by 9 points.
Momentum
AVAVAVAV on the Momentum factor, by 9 points.
Lower downside
CRSCRS on Risk Resilience, by 13 points.
Analyst upside
AVAVAVAV on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors CRS, analyst targets favor AVAV. That disagreement is the most useful thing on this page.
| Measure | AVAV | CRS | Note |
|---|---|---|---|
| Implied upside to target | +71.1% | +58.3% | AVAV has more room |
| Target dispersion | +59.7% | +4.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 24 | 8 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor CRS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | CRS | 39 vs 45 |
| Fundamentals | CRS | revenue growth -25.1% vs -6.2%; gross margin 26.5% vs 31.2% |
| Valuation | AVAV | Value 50 vs 41 |
| Technicals | AVAV | Price vs 50-day -13% vs -19.9%; vs 200-day -32.9% vs -34% |
| Risk Resilience | CRS | Risk Resilience 35 vs 48 |
| Analyst expectations | AVAV | Target upside 71.1% vs 58.3% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVAV and CRS and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 6 points.
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CRS.
How the comparison changed
120 daily snapshots · May 27 – Nov 13CRS lead: Weakening — the AIQ differential moved from 9 to 6 points over 30 sessions.
- Today
- CRS +6
- 39 vs 45
- 7 sessions ago
- CRS +5
- 39 vs 44
- 30 sessions ago
- CRS +9
- 41 vs 50
- 90 sessions ago
- CRS +28
- 42 vs 70
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
0 bullish / 3 bearish / 2 neutral
Only AVAV
- ADX Trend Weakening — neutral, trend, medium horizon
0 bullish / 3 bearish / 1 neutral
No signal that the other name lacks.
Both carry 4 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode, Beta Spike Warning, Downtrend Structure Active.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.75%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.66%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AVAV closes the Quality gap — currently 27 points behind, the largest single contributor to CRS's edge.
- 2AVAV's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3CRS starts generating bearish momentum or trend signals.
- 4The narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 6-point move would eliminate CRS's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
CRS leads on balance| Metric | AVAV | CRS |
|---|---|---|
| Revenue growth (YoY) | -25.1% | -6.2% |
| EPS growth (YoY) | 79.2% | 0.3% |
| Gross margin | 26.5% | 31.2% |
| Operating margin | -0.6% | 23.4% |
| Return on equity (TTM) | -0.1% | 7.4% |
| Debt to equity | 0.19 | 0.32 |
Performance
Split across windows| Metric | AVAV | CRS |
|---|---|---|
| 1 week (5 sessions) | 4.2% | 4.8% |
| 1 month (20 sessions) | -3.5% | -22.7% |
| 3 months (63 sessions) | -35.1% | -46.2% |
| 6 months (126 sessions) | -25.6% | -28.7% |
| Year to date | -51.4% | -7.4% |
| 1 year (252 sessions) | -63.7% | -12.2% |
Technicals
AVAV has the stronger structure| Metric | AVAV | CRS |
|---|---|---|
| RSI (14) | 43.7 | 37.2 |
| ADX (14) | 18.5 | 47.1 |
| Price vs 50-day | -13% | -19.9% |
| Price vs 200-day | -32.9% | -34% |
| Volatility (1M, annualized) | 88.7% | 92.7% |
Risk
CRS is the more resilient| Metric | AVAV | CRS |
|---|---|---|
| Beta | 2 | 1.65 |
| Sharpe ratio | -0.87 | -0.05 |
| Sortino ratio | -1.23 | -0.06 |
| Max drawdown | -74% | -55.1% |
| Current drawdown | -70.1% | -52.9% |
| Annualized volatility | 77.2% | 49.4% |
| Value at risk (95%) | -7.5% | -4.6% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AVAV or CRS?
On the Algovestiq AIQ Score, CRS is the stronger of the two as of Nov 15, 2026, scoring 45 against AVAV's 39. The edge comes from quality and risk resilience. AVAV is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AVAV or CRS the better buy right now?
CRS carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor CRS over AVAV?
The composite weights Quality, Value, Momentum and Risk Resilience. CRS leads Quality by 27 points; CRS leads Risk Resilience by 13 points; AVAV leads Value by 9 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AVAV or CRS?
Analyst price targets imply +71.1% upside for AVAV and +58.3% for CRS, so the Street currently favors AVAV. That points the opposite way to the AIQ Score, which favors CRS. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AVAV or CRS?
AVAV is the better-valued of the two on the peer-relative Value factor. AVAV on the peer-relative Value factor, by 9 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AVAV or CRS?
AVAV on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AVAV or CRS?
AVAV on the Momentum factor, by 9 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AVAV or CRS?
CRS is the more resilient of the two, so the other name carries the higher downside risk. CRS on Risk Resilience, by 13 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AVAV more profitable than CRS?
CRS leads on the comparable margin measures — gross margin 26.5% vs 31.2%; operating margin -0.6% vs 23.4%; ttm roe -0.1% vs 7.4%.
Is CRS's lead over AVAV getting stronger or weaker?
CRS lead: Weakening — the AIQ differential moved from 9 to 6 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the AVAV vs CRS verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVAV closes the Quality gap — currently 27 points behind, the largest single contributor to CRS's edge; AVAV's Death Cross Active resolves — a bearish trend rule currently active against it; CRS starts generating bearish momentum or trend signals; the narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 6-point move would eliminate CRS's advantage entirely.
What do the current signals say about AVAV and CRS?
AVAV: 0 bullish / 3 bearish / 2 neutral. CRS: 0 bullish / 3 bearish / 1 neutral. The most decision-relevant rule on AVAV is Death Cross Active (bearish, long horizon). On CRS it is Death Cross Active (bearish, long horizon).
Compare AVAV and CRS with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.